ADIPOQ and metabolic syndrome: MHO demonstrated abnormal metabolism in fat distribution, adiponectin pathway, chronic inflammation, oxidative stress, and various omics at the microlevel, despite having normal metabolism in the criteria of metabolic syndrome and insulin resistance.